Vyome Therapeutics Inc CEO Venkat Nelabhotla sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
Vyome Therapeutics is a clinical stage speciality pharmaceutical company, with platform technologies and a pipeline of drugs for antibiotic-resistant acne and other skin pathogens.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Director Interviews
Proactive analyst Ryan Long focuses on Trident Royalties (LON:TRR) a newly AIM-listed diversified mining royalty and streaming business. The company aims to provide investors with exposure to a broad range of development and cash-generating mining assets across the base metal, precious metal,...
Director Interviews
Ipsidy joins Fast Identity Online Alliance, a consumer...
Industry & services
Prev article
